No added cTBS anxiety efficacy in 2025 combined trial

Active cTBS+AMT not superior to sham cTBS+AMT

Registry status

• Type: constraint
• Year: 2025
• Population: young-adulthood
• Construct role: efficacy-constraint
• Source grade: A
• Attribution: direct-fanti
• Verification: fulltext-verified

Outgoing relationships

• constrains → Anxiety symptom change — historical: high; evidentiary: high. Boundary: AMT symptom change cannot be attributed to added active cTBS

Incoming relationships

• Repeated cTBS + AMT feasibility trial → supports — historical: high; evidentiary: high